Cellect Biotechnology Reports Fourth Quarter and Full Year 2018 Results and Recent Corporate Progress

TEL AVIV, Israel: Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of a novel stem cell production technology, today announced operating and financial results for the fourth quarter and full year ended December 31
error: Content is protected !!